Drug Database
Back to search

Belgium· BE-AMP-SAM505155-00

Idelvion 2000 IU

A coagulation factor ix product containing albutrepenonacog alfa, registered in Belgium by CSL Behring. The same ATC class is registered in 12 of our 19 countries.

ATC B02BD04

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedIdelvion 2000 IUATCB02BD04REGISTER NO.BE-AMP-SAM505155-00PACKS LISTED4CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about albutrepenonacog alfaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Coagulation factor ix is registered in 12 of 19 countries.

Countries holding a registration under ATC B02BD04 (coagulation factor ix), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search coagulation factor ix products by name

Coagulation factor ix · ATC B02BD04

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Albutrepenonacog Alfa
Manufacturer
CSL Behring
Country
Belgium (BE)
ATC code
B02BD04
ATC class
Coagulation factor IX
Defined daily dose
600 E, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 4

2 priced
  • be_apb
    4799672
    EUR 3855.14
  • be_apb
    3430378
    EUR 3855.14
  • be_apb
    7740061
  • be_apb
    7717168

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for coagulation factor ix.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check coagulation factor ix against other medicinesHow interaction checks work

Coagulation factor ix · interactions on record

3 records

  • 2 severe
  • 1 moderate

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • PegvaliaseA16AB19moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Coagulation factor ix in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All coagulation factor ix products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Idelvion
  • Liechtenstein · Idelvion
  • Norway · Idelvion

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/802c2544-9129-4fc4-a2b3-9c9575562989
GET /v1/drugs/802c2544-9129-4fc4-a2b3-9c9575562989?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Idelvion 2000 IU",
  "name_fr": "Idelvion 2000 IU",
  "name_nl": "Idelvion 2000 IU",
  "amp_code": "SAM505155-00",
  "strengths": [
    "2000.0000",
    "8.6000"
  ],
  "pack_count": 2,
  "substances": [
    "Albutrepenonacog Alfa",
    "Mannitol",
    "Sucrose",
    "Polysorbate 80",
    "Sodium"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Coagulation Factor IX",
  "authorisation_numbers": [
    "EU/1/16/1095/004"
  ]
}
API referenceMCP serverPlans

See everything about coagulation factor ix.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console